Table 4.
Geometric means (percentage of the coefficient of variation) of antibody titers taken 14 and 28 days after pneumococcal vaccination
| Group | n | Baseline (μg/ml) | 14 days post-vaccination (μg/ml) | 28 days post-vaccination (μg/ml) |
| Serotype 14 | ||||
| Group A | 20 | 1.9 (112) | 20.5 (236) | 23.5 (199) |
| Group B | 20 | 1.9 (132) | 15.5 (105) | 15.4 (111)a |
| Group C | 19 | 1.8 (201) | 12.0 (195) | 12.8 (250) |
| Group D | 19 | 1.8 (125) | 18.0 (155) | 12.6 (141) |
| Serotype 2 | ||||
| Group A | 20 | 1.0 (163) | 13.4 (113) | 15.4 (110) |
| Group B | 20 | 1.1 (84) | 12.3 (109) | 13.2 (107)a |
| Group C | 19 | 0.8 (90) | 4.1 (118) | 4.8 (115) |
| Group D | 19 | 0.7 (122) | 7.0 (132) | 7.7 (136) |
| Serotype 23F | ||||
| Group A | 20 | 0.9 (101) | 3.0 (112) | 3.3 (113) |
| Group B | 20 | 1.8 (124) | 5.6 (87) | 4.9 (89)a |
| Group C | 19 | 1.2 (158) | 4.5 (112) | 5.1 (106) |
| Group D | 19 | 1.5 (125) | 6.2 (92) | 6.7 (90) |
| Serotype 8 | ||||
| Group A | 20 | 1.5 (120) | 10.1 (138) | 9.6 (114) |
| Group B | 20 | 2.3 (104) | 12.0 (61) | 10.5 (81)a |
| Group C | 19 | 1.4 (104) | 4.0 (68) | 4.4 (64) |
| Group D | 19 | 1.6 (74) | 5.1 (144) | 5.2 (106) |
| Serotype 9V | ||||
| Group A | 20 | 0.9 (148) | 6.1 (102) | 6.4 (99) |
| Group B | 20 | 1.3 (158) | 4.0 (97) | 3.9 (101)a |
| Group C | 19 | 0.9 (190) | 3.0 (147) | 3.2 (108) |
| Group D | 19 | 0.9 (119) | 2.0 (107) | 2.3 (106) |
| Serotype 19F | ||||
| Group A | 20 | 5.3 (95) | 13.0 (125) | 13.9 (150) |
| Group B | 20 | 10.3 (127) | 19.9 (105) | 19.6 (97)a |
| Group C | 19 | 4.3 (117) | 10.0 (178) | 10.3 (180) |
| Group D | 19 | 5.6 (75) | 9.9 (89) | 10.3 (88) |
| Serotype 6B | ||||
| Group A | 20 | 1.6 (103) | 5.9 (197) | 6.1 (204) |
| Group B | 20 | 3.1 (126) | 7.8 (87) | 7.1 (95)a |
| Group C | 19 | 1.9 (140) | 4.6 (147) | 4.6 (141) |
| Group D | 19 | 1.8 (114) | 3.5 (159) | 3.5 (151) |
an = 19.